Advanced Nutriceuticals, LLC
Complete recall history across all FDA and CPSC categories — 17 total recalls
Advanced Nutriceuticals, LLC appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.
Drug Recalls (17)
FDA drug safety enforcement actions by Advanced Nutriceuticals, LLC
| Date | Product | Reason | Class |
|---|---|---|---|
| Nov 30, 2020 | PT-141, 10 MG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, India... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | IPAMORELIN, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | NANDROLONE, 200 MCG/ML, 2 ML, The Guyer Institute of Molecular Medicine, Indi... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | DSIP, 1000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indi... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | Pentosan Polysulfate, 300 MG/ML, 5 ML vial, The Guyer Institute of Molecular ... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | GHK-CU, 10 MG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, India... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | FGL, 10 MG/ML, 3 ML vial, The Guyer Institute of Molecular Medicine, Indianap... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | B12 for Injection, 2 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medi... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | CJC-1295, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, ... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | HIGH DOSE B12, 10 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicin... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | THYMOSIN BETA - 4, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular M... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | CEREBROLYSIN, 107.5 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medic... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | AOD-9604, 1200 MCG/ML, 5 ML vial The Guyer Institute of Molecular Medicine, I... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | LL-37, 2000 MCG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Ind... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | THYMOSIN ALPHA, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medi... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | GHRP, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indi... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
| Nov 30, 2020 | BPC-157, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, I... | Lack of Assurance of Sterility: due to concerns with production processes whi... | Class II |
Frequently Asked Questions
A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.
Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.
The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.
Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.
Explore More Recalls
Search recalls by category, state, reason, or firm across all our databases.